Company intelligence / Profile preview

Bio-Mer

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Bio-Mer is a biotechnology company focused on the development of advanced biopolymer-based solutions for medical applications. The company specializes in creating biocompatible materials designed for wound healing, the prevention of surgical adhesions, and controlled drug delivery systems. By leveraging its proprietary biopolymer technology, Bio-Mer aims to improve patient outcomes in surgical and regenerative medicine. Their products are engineered to be biodegradable and integrate seamlessly with human tissue, providing a scaffold for natural healing processes.

Therapeutic areas: OtherDermatology
Modalities: BiopolymerDevice
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Bio-Mer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Mer.

Explore the full profile